Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01562899
Title A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Array BioPharma

colorectal cancer

Advanced Solid Tumor

pancreatic adenocarcinoma



Binimetinib + Ganitumab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL

Additional content available in CKB BOOST